KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Non-Current Debt (2016 - 2025)

Historic Non-Current Debt for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $4.3 billion.

  • Jazz Pharmaceuticals' Non-Current Debt fell 2875.97% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 2875.97%. This contributed to the annual value of $6.1 billion for FY2024, which is 1898.31% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' Non-Current Debt is $4.3 billion, which was down 2875.97% from $4.3 billion recorded in Q2 2025.
  • In the past 5 years, Jazz Pharmaceuticals' Non-Current Debt registered a high of $6.5 billion during Q2 2021, and its lowest value of $1.9 billion during Q1 2021.
  • Its 5-year average for Non-Current Debt is $5.4 billion, with a median of $5.7 billion in 2023.
  • In the last 5 years, Jazz Pharmaceuticals' Non-Current Debt soared by 23884.79% in 2021 and then plummeted by 2875.97% in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Non-Current Debt (Quarter) stood at $6.0 billion in 2021, then fell by 5.41% to $5.7 billion in 2022, then decreased by 10.28% to $5.1 billion in 2023, then increased by 18.98% to $6.1 billion in 2024, then fell by 28.72% to $4.3 billion in 2025.
  • Its Non-Current Debt was $4.3 billion in Q3 2025, compared to $4.3 billion in Q2 2025 and $5.3 billion in Q1 2025.